A rapid and selective liquid chromatographic/tandem mass spectrometric method for determination of fosfomycin was developed and validated. Following protein-precipitation, the analyte and internal standard (fudosteine) were separated from human plasma using an inocra-
tic mobile phase on an UltimateTM XB-CN column. An API 4000 tandem mass spectrometer equipped with Turbo IonSpray ionization source was used as detector and was operated in the negative ion mode. Multiple reaction monitoring using the precursor to product ion combinatio-
ns of m/z 137→79 and m/z 178→91 was performed to quantify fosfomycin and fudosteine, respectively. The method was linear in the conce-
ntration range of 0.10–12.0μg/mL using 50μL of plasma. The lower limit of quantification was 0.10μg/mL. The intra- and inter-day relat-
ive standard deviation over the entire concentration range was less than 10.6%. Accuracy determined at three concentrations (0.25, 1.00 and 8.00μg/mL for fosfomycin) ranged from −1.0% to −4.2% in terms of relative error. Each plasma sample was chromatographed within 5.0 min. The method was successfully used in a bioequivalence study of fosfomycin in human plasma after an oral administration of capsules containing 1.0 g fosfomycin (∼1.3 g calcium fosfomycin).
赛默飞实验室产品焕新计划有奖调研！
【七月征文】不一YOUNG实验“猿”
报名开启：ICS2024第十三届光谱网络会议！
推荐收藏！盘点中药材及饮片检测解决方案
